HSIC - Henry Schein Inc

HSIC - Henry Schein Inc

https://www.henryschein.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Albemarle ( NYSE:ALB ) , Domo ( NASDAQ:DOMO )

Benzinga • 2 weeks, 6 days ago • score: 0.61

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Canaccord Genuity analyst Kingsley Crane upgraded Okta, Inc.

Why Is Henry Schein Stock Falling Tuesday? - Henry Schein ( NASDAQ:HSIC )

Benzinga • 1 month, 1 week ago • score: 0.32

Q2 EPS of $1.10 missed estimates by $0.10; revenue rose 3.3% to $3.34 billion, topping expectations. The company sees over $100 million in annual savings from restructuring, affirms 2025 EPS and revenue guidance. Get special access to three exclusive "Top 10 Stocks" power lists today, updated ...

Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top

Zacks Commentary • 1 month, 1 week ago • score: 0.19

HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.

Henry Schein ( HSIC ) Q2 Earnings Lag Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.18

Henry Schein (HSIC) delivered earnings and revenue surprises of -6.78% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Henry Schein to Report Q2 Earnings: What's in Store for the Stock?

Zacks Commentary • 1 month, 2 weeks ago • score: 0.37

HSIC eyes modest Q2 gains, with dental, medical and specialty segments showing signs of steady momentum.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.

52W High

$82.49

52W Low

$60.56

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.86

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

22.32

Forward P/E (<15 better)

13.35

EV/EBITDA (<8 favorable)

12.48

EV/Revenue (<3 favorable)

0.91

P/S (TTM) (<3 favorable)

0.66

P/B (<3 favorable)

2.44

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.87%

Institutions (25–75% balanced)

114.30%

Shares Outstanding

121,268,000

Float

101,947,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

12,773,000,000

Gross Profit (TTM)

4,002,000,000

EPS (TTM)

3.11

Profit Margin (>10% good)

0.03%

Operating Margin (TTM) (higher better)

0.05%

ROE (TTM) (>15% strong)

0.08%

EPS YoY (Quarterly) (>10% good)

-0.13

Revenue YoY (Quarterly) (>8% good)

0.03

Momentum

Bearish momentum

Value

-0.1089

Previous

-0.1934

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025